(46.70 ±27.08 vs. 27.08 ±16.29, p < 0.05; 49.39 ±28.32 vs. 9.78 ±3.87, respectively). In women with minimal-mild endometriosis, only the plasma level of p < 0.05). In women with moderatesevere endometriosis, plasma levels of IL-6 and CA-125 were significantly increased, and those of Epo and tumor necrosis factor α (TNF-α) were significantly decreased (44.53 ±31.07 vs. 27.08 ±16.29, p < 0.05; 57.84 ±61.44 vs. 9.78 ±3.87, p < 0.05; 26.60 ±10.19 vs. 30.32 ±7.94, p < 0.05; 58.61 ±7.93 vs. 65.40 ±9.86, p < 0.05, respectively). The area under curve (AUC) for Epo, 0.322, 0.729 and 0.864, respectively.
Conclusions:The results of our study show that progression of endometriosis is associated with the elevated level of serum IL-6. Clearly, larger prospective studies are required to determine the diagnostic potential of measuring circulating inflammatory cytokine levels like IL-6 in endometriosis.